Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery (TXA)

Clinical Trial ID NCT03856164

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03856164

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	WHO analysis of causes of maternal death: a systematic review.	Lancet	2006	20.24
2	Global causes of maternal death: a WHO systematic analysis.	Lancet Glob Health	2014	7.11
3	Tranexamic acid: a review of its use in surgery and other indications.	Drugs	1999	3.09
4	Epidemiology of postpartum haemorrhage: a systematic review.	Best Pract Res Clin Obstet Gynaecol	2008	1.82
5	Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.	Drugs	2012	1.46
6	Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*.	Anesthesiology	2015	1.42
7	Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.	Lancet	2016	1.38
8	Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry.	BJOG	2009	0.96
9	National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage.	Obstet Gynecol	2015	0.86
10	Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.	Lancet	2017	0.83
11	Calculated blood loss in severe obstetric hemorrhage and its relation to body mass index.	Am J Perinatol	2012	0.77
12	A Renewed Focus on Maternal Health in the United States.	N Engl J Med	2017	0.75
13	Practice Bulletin No. 183: Postpartum Hemorrhage.	Obstet Gynecol	2017	0.75